Corresponding Author: Gary W. Falk, MD, MS, Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd, 7th Floor, South Pavilion, Philadelphia, PA 19104 (gary.falk@pennmedicine.upenn.edu).
Accepted for Publication: August 17, 2021.
Author Contributions: Drs Muir and Falk had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Both authors.
Acquisition, analysis, or interpretation of data: Both authors.
Drafting of the manuscript: Both authors.
Critical revision of the manuscript for important intellectual content: Both authors.
Administrative, technical, or material support: Both authors.
Conflict of Interest Disclosures: Dr Muir reported receiving research funding from Allakos. Dr Falk reported receiving research funding from Allakos, Arena, Adare/Ellodi, Bristol Myers Squibb, Celgene, Lucid, Regeneron, and Shire/Takeda and is a consultant for Allakos, Adare/Ellodi, Bristol Myers Squibb/Celgene, Lucid, Sanofi, and Shire/Takeda.
Funding/Support: This work was supported in part by the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Center for Molecular Studies in Digestive and Liver Disease (P30DK050306) and by the Consortium for Eosinophilic Gastrointestinal Disease Research (CEGIR) (U54 AI117804), which is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), and is funded through collaboration between the National Institute of Allergy and Infectious Diseases, NIDDK, and NCATS. CEGIR is also supported by patient advocacy groups including the American Partnership for Eosinophilic Disorders, Campaign Urging Research for Eosinophilic Diseases, and Eosinophilic Family Coalition. As a member of the RDCRN, CEGIR is also supported by its data management and coordinating center (U2CTR002818). Dr Muir is funded by NIH grants R01 DK124266-01 and R21TR00303902.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
2.Navarro
P , Arias
Á , Arias-González
L , Laserna-Mendieta
EJ , Ruiz-Ponce
M , Lucendo
AJ . Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies.
Aliment Pharmacol Ther. 2019;49(9):1116-1125. doi:
10.1111/apt.15231
PubMedGoogle ScholarCrossref 6.Aceves
SS , Chen
D , Newbury
RO , Dohil
R , Bastian
JF , Broide
DH . Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction.
J Allergy Clin Immunol. 2010;126(6):1198-204.e4. doi:
10.1016/j.jaci.2010.08.050
PubMedGoogle ScholarCrossref 7.Alexander
ES , Martin
LJ , Collins
MH ,
et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis.
J Allergy Clin Immunol. 2014;134(5):1084-1092.e1. doi:
10.1016/j.jaci.2014.07.021
PubMedGoogle ScholarCrossref 14.Dellon
ES , Gibbs
WB , Fritchie
KJ ,
et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease.
Clin Gastroenterol Hepatol. 2009;7(12):1305-1313. doi:
10.1016/j.cgh.2009.08.030
PubMedGoogle ScholarCrossref 15.Hiremath
GS , Hameed
F , Pacheco
A , Olive
A , Davis
CM , Shulman
RJ . Esophageal food impaction and eosinophilic esophagitis: a retrospective study, systematic review, and meta-analysis.
Dig Dis Sci. 2015;60(11):3181-3193. doi:
10.1007/s10620-015-3723-8
PubMedGoogle ScholarCrossref 16.Chang
JW , Olson
S , Kim
JY ,
et al. Loss to follow-up after food impaction among patients with and without eosinophilic esophagitis.
Dis Esophagus. 2019;32(12):1-4. doi:
10.1093/dote/doz056
PubMedGoogle Scholar 18.Warners
MJ , Oude Nijhuis
RAB , de Wijkerslooth
LRH , Smout
AJPM , Bredenoord
AJ . The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort.
Am J Gastroenterol. 2018;113(6):836-844. doi:
10.1038/s41395-018-0052-5PubMedGoogle ScholarCrossref 19.Hirano
I , Moy
N , Heckman
MG , Thomas
CS , Gonsalves
N , Achem
SR . Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system.
Gut. 2013;62(4):489-495. doi:
10.1136/gutjnl-2011-301817
PubMedGoogle ScholarCrossref 20.Dellon
ES , Gonsalves
N , Hirano
I , Furuta
GT , Liacouras
CA , Katzka
DA ; American College of Gastroenterology. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Am J Gastroenterol. 2013;108(5):679-692. doi:
10.1038/ajg.2013.71
PubMedGoogle ScholarCrossref 22.Safroneeva
E , Straumann
A , Coslovsky
M ,
et al; International Eosinophilic Esophagitis Activity Index Study Group. Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis.
Gastroenterology. 2016;150(3):581-590.e4. doi:
10.1053/j.gastro.2015.11.004
PubMedGoogle ScholarCrossref 23.Katzka
DA , Smyrk
TC , Alexander
JA ,
et al. Accuracy and safety of the cytosponge for assessing histologic activity in eosinophilic esophagitis: a two-center study.
Am J Gastroenterol. 2017;112(10):1538-1544. doi:
10.1038/ajg.2017.244
PubMedGoogle ScholarCrossref 24.Ackerman
SJ , Kagalwalla
AF , Hirano
I ,
et al. One-hour esophageal string test: a nonendoscopic minimally invasive test that accurately detects disease activity in eosinophilic esophagitis.
Am J Gastroenterol. 2019;114(10):1614-1625. doi:
10.14309/ajg.0000000000000371
PubMedGoogle ScholarCrossref 27.Shoda
T , Wen
T , Aceves
SS ,
et al; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.
Lancet Gastroenterol Hepatol. 2018;3(7):477-488. doi:
10.1016/S2468-1253(18)30096-7
PubMedGoogle ScholarCrossref 30.Carlson
DA , Lin
Z , Hirano
I , Gonsalves
N , Zalewski
A , Pandolfino
JE . Evaluation of esophageal distensibility in eosinophilic esophagitis: an update and comparison of functional lumen imaging probe analytic methods.
Neurogastroenterol Motil. 2016;28(12):1844-1853. doi:
10.1111/nmo.12888
PubMedGoogle ScholarCrossref 32.Rank
MA , Sharaf
RN , Furuta
GT ,
et al; AGA Institute; Joint Task Force on Allergy-Immunology Practice Parameters collaborators; AGA Institute; Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters.
Gastroenterology. 2020;158(6):1789-1810.e15. doi:
10.1053/j.gastro.2020.02.039
PubMedGoogle ScholarCrossref 34.Moayyedi
P , Eikelboom
JW , Bosch
J ,
et al; COMPASS Investigators. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin.
Gastroenterology. 2019;157(3):682-691.e2. doi:
10.1053/j.gastro.2019.05.056
PubMedGoogle ScholarCrossref 38.Hirano
I , Chan
ES , Rank
MA ,
et al; AGA Institute Clinical Guidelines Committee; Joint Task Force on Allergy-Immunology Practice Parameters. AGA Institute and the Joint Task Force on Allergy-Immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis.
Gastroenterology. 2020;158(6):1776-1786. doi:
10.1053/j.gastro.2020.02.038
PubMedGoogle ScholarCrossref 39.Gonsalves
N , Yang
GY , Doerfler
B , Ritz
S , Ditto
AM , Hirano
I . Elimination diet effectively treats eosinophilic esophagitis in adults: food reintroduction identifies causative factors.
Gastroenterology. 2012;142(7):1451-9.e1. doi:
10.1053/j.gastro.2012.03.001
PubMedGoogle ScholarCrossref 40.Doerfler
B , Bryce
P , Hirano
I , Gonsalves
N . Practical approach to implementing dietary therapy in adults with eosinophilic esophagitis: the Chicago experience.
Dis Esophagus. 2015;28(1):42-58. doi:
10.1111/dote.12175
PubMedGoogle ScholarCrossref 41.Molina-Infante
J , Bredenoord
AJ , Cheng
E ,
et al; PPI-REE Task Force of the European Society of Eosinophilic Oesophagitis (EUREOS). Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.
Gut. 2016;65(3):524-531. doi:
10.1136/gutjnl-2015-310991
PubMedGoogle ScholarCrossref 42.Wen
T , Dellon
ES , Moawad
FJ , Furuta
GT , Aceves
SS , Rothenberg
ME . Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.
J Allergy Clin Immunol. 2015;135(1):187-197. doi:
10.1016/j.jaci.2014.08.043
PubMedGoogle ScholarCrossref 43.Dellon
ES , Speck
O , Woodward
K ,
et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.
Am J Gastroenterol. 2013;108(12):1854-1860. doi:
10.1038/ajg.2013.363
PubMedGoogle ScholarCrossref 45.Cheng
E , Zhang
X , Wilson
KS ,
et al. JAK-STAT6 pathway inhibitors block eotaxin-3 secretion by epithelial cells and fibroblasts from esophageal eosinophilia patients: promising agents to improve inflammation and prevent fibrosis in EOE.
PLoS One. 2016;11(6):e0157376. doi:
10.1371/journal.pone.0157376
PubMedGoogle Scholar 46.Lucendo
AJ , Arias
Á , Molina-Infante
J . Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis.
Clin Gastroenterol Hepatol. 2016;14(1):13-22.e1. doi:
10.1016/j.cgh.2015.07.041
PubMedGoogle ScholarCrossref 47.Laserna-Mendieta
EJ , Casabona
S , Guagnozzi
D ,
et al; EUREOS EoE CONNECT Research group. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.
Aliment Pharmacol Ther. 2020;52(5):798-807. doi:
10.1111/apt.15957
PubMedGoogle ScholarCrossref 48.Freedberg
DE , Kim
LS , Yang
YX . The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association.
Gastroenterology. 2017;152(4):706-715. doi:
10.1053/j.gastro.2017.01.031
PubMedGoogle ScholarCrossref 49.Lucendo
AJ , Miehlke
S , Schlag
C ,
et al; International EOS-1 Study Group. Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial.
Gastroenterology. 2019;157(1):74-86.e15. doi:
10.1053/j.gastro.2019.03.025
PubMedGoogle ScholarCrossref 50.Philpott
H , Dougherty
MK , Reed
CC ,
et al. Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis.
Aliment Pharmacol Ther. 2018;47(8):1071-1078. doi:
10.1111/apt.14573
PubMedGoogle ScholarCrossref 51.Hirano
I , Collins
MH , Katzka
DA ,
et al; ORBIT1/SHP621-301 Investigators. Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial.
Clin Gastroenterol Hepatol. 2021;S1542-3565(21)00456-0. doi:
10.1016/j.cgh.2021.04.022PubMedGoogle Scholar 52.Moawad
FJ , Molina-Infante
J , Lucendo
AJ , Cantrell
SE , Tmanova
L , Douglas
KM . Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis.
Aliment Pharmacol Ther. 2017;46(2):96-105. doi:
10.1111/apt.14123
PubMedGoogle ScholarCrossref 53.Dougherty
M , Runge
TM , Eluri
S , Dellon
ES . Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis.
Gastrointest Endosc. 2017;86(4):581-591.e3. doi:
10.1016/j.gie.2017.04.028
PubMedGoogle ScholarCrossref 54.Schoepfer
AM , Gonsalves
N , Bussmann
C ,
et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation.
Am J Gastroenterol. 2010;105(5):1062-1070. doi:
10.1038/ajg.2009.657
PubMedGoogle ScholarCrossref 55.Runge
TM , Eluri
S , Woosley
JT , Shaheen
NJ , Dellon
ES . Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis.
Dis Esophagus. 2017;30(7):1-7. doi:
10.1093/dote/dox042
PubMedGoogle ScholarCrossref 58.Reed
CC , Tappata
M , Eluri
S , Shaheen
NJ , Dellon
ES . Combination therapy with elimination diet and corticosteroids is effective for adults with eosinophilic esophagitis.
Clin Gastroenterol Hepatol. 2019;17(13):2800-2802. doi:
10.1016/j.cgh.2019.03.009
PubMedGoogle ScholarCrossref 59.Dellon
ES , Kim
HP , Sperry
SLW , Rybnicek
DA , Woosley
JT , Shaheen
NJ . A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease.
Gastrointest Endosc. 2014;79(4):577-85.e4. doi:
10.1016/j.gie.2013.10.027
PubMedGoogle ScholarCrossref 60.Dellon
ES , Woosley
JT , Arrington
A ,
et al. Rapid recurrence of eosinophilic esophagitis activity after successful treatment in the observation phase of a randomized, double-blind, double-dummy trial.
Clin Gastroenterol Hepatol. 2020;18(7):1483-1492.e2. doi:
10.1016/j.cgh.2019.08.050
PubMedGoogle ScholarCrossref 61.Greuter
T , Bussmann
C , Safroneeva
E ,
et al. Long-term treatment of eosinophilic esophagitis with swallowed topical corticosteroids: development and evaluation of a therapeutic concept.
Am J Gastroenterol. 2017;112(10):1527-1535. doi:
10.1038/ajg.2017.202
PubMedGoogle ScholarCrossref 63.Straumann
A , Lucendo
AJ , Miehlke
S ,
et al; International EOS-2 Study Group. Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis.
Gastroenterology. 2020;159(5):1672-1685.e5. doi:
10.1053/j.gastro.2020.07.039
PubMedGoogle ScholarCrossref